Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCamellia Regulatory News (CAM)

Share Price Information for Camellia (CAM)

Share Price is delayed by 15 minutes
Get Live Data
5,500.00    0.00 (0.00%)
Bid:
5,400.00
Ask:
5,500.00
Spread: 100.00 (1.852%)
Market Cap: £139.03m
CAM Live PriceLast checked at - London Stock Exchange

Intraday Camellia Share Chart

BF&M Strategic Review Conclusion

30 Jan 2023 07:00

RNS Number : 1765O
Camellia PLC
30 January 2023
 

30 January 2023

Camellia Plc

 

(the "Company" or the "Group")

 

Associate Company Update

 

Camellia Plc (CAM.L) notes that its 36.9% owned associate company, BF&M Limited ("BF&M"), a listed Bermudian insurance business, has issued a statement that it has concluded its previously announced strategic review. The BF&M Board has determined that continuing to execute its strategic plan on a standalone basis is in the best interest of all BF&M shareholders, that BF&M remains in a strong capital position, has the right strategic plan already in place and a foundation for growth. BF&M remains focussed on taking decisive steps to create value for its shareholders. The full text of BF&M's announcement can be found in Appendix 1 to this announcement.

 

 

Enquiries

 

Camellia Plc 01622 746655

Malcolm Perkins, Chairman

Susan Walker, Chief Financial Officer

 

Panmure Gordon 020 7886 2500

Nominated Adviser and Broker

Emma Earl

Rupert Dearden

 

Maitland/AMO

PR

William Clutterbuck 07785 292617

 

 

 

  

Appendix 1

BF&M Concludes Strategic Review

 

Hamilton, Bermuda, 7 December 2022 - BF&M Limited ("BF&M", "the BF&M Group" or "the Company") today announced that its Board of Directors (the "Board") concluded its previously announced review of strategic alternatives (the "Strategic Review"). After a comprehensive process with the assistance of Desjardins Capital Markets, the Board has determined that continuing to execute its strategic plan on a standalone basis is in the best interest of all shareholders.

 

Anthony Joaquin, Acting Chairman of the Board, said, "During our review, the Board assessed a comprehensive range of potential outcomes. Ultimately, this process reinforced our confidence that BF&M has the right strategic plan already in place to maximize value for shareholders. With this evaluation concluded, the Board is fully committed to supporting Abigail and the rest of the Company's leadership team as they continue to execute this plan."

 

Abigail Clifford, Chief Executive Officer, said, "BF&M is entering 2023 with a strong capital position and foundation for growth, including the highest AM Best financial strength rating of any domestic insurers operating in Bermuda and the Caribbean. We remain focused on taking decisive steps to create value for shareholders, while providing best-in-class support to our clients as they navigate a challenging economic environment and positioning BF&M as an employer of choice."

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDBKLLLXFLFBBF
Date   Source Headline
4th May 20079:39 amRNSAnnual Report and Accounts
26th Apr 20071:00 pmRNSFinal Results
18th Apr 20074:44 pmRNSDisposal of investment
18th Apr 20074:39 pmRNSHolding(s) in Company
13th Apr 20073:54 pmRNSKakuzi Limited
20th Dec 20061:56 pmRNSTotal Voting Rights
13th Oct 20063:26 pmRNSTransaction in Own Shares
5th Oct 200610:21 amRNSInterim Report
28th Sep 200612:30 pmRNSInterim Results
27th Sep 200610:09 amRNSAcquisition
11th Aug 20062:29 pmRNSAcquisition
28th Jul 20069:27 amRNSDirectorate Change
12th Jun 200610:52 amRNSResult of AGM
8th Jun 200612:16 pmRNSAGM Statement
7th Jun 200610:31 amRNSAnnual Information Update
8th May 20064:17 pmRNSReport and accounts 2005
27th Apr 20064:05 pmRNSFinal Results
25th Nov 200510:37 amRNSDirectorate Change
18th Nov 20053:21 pmRNSHolding(s) in Company
18th Nov 20052:42 pmRNSDirector/PDMR Sharehldg-Rep
17th Nov 20053:44 pmRNSHolding(s) in Company
17th Nov 20053:43 pmRNSDirector/PDMR Shareholding
17th Nov 20057:01 amRNSAdditional Listing
14th Nov 200512:05 pmRNSStmt re Additional Listing
14th Nov 200512:00 pmRNSResult of Court Hearing
31st Oct 200511:42 amRNSResult of Court Meeting
31st Oct 200511:34 amRNSResult of EGM
30th Sep 200510:40 amRNSEPT Disclosure
29th Sep 20054:43 pmRNSCircular and Interim Report
28th Sep 20057:03 amRNSOffer for Linton Park Plc
28th Sep 20057:02 amRNSOffer for Linton Park Plc
28th Sep 20057:00 amRNSInterim Results
15th Sep 20054:44 pmRNSHolding(s) in Company
15th Sep 20054:34 pmRNSTransfer of Shares
9th Sep 200511:30 amRNSEPT Disclosure
5th Sep 200510:45 amRNSEPT Disclosure
1st Sep 200511:55 amRNSEPT Disclosure
30th Aug 200510:48 amRNSEPT Disclosure
26th Aug 200510:59 amRNSEPT Disclosure
26th Aug 200510:59 amRNSRule 8.3 - Camellia plc
24th Aug 200510:39 amRNSEPT Disclosure
19th Aug 200510:35 amRNSEPT Disclosure
18th Aug 200511:26 amRNSEPT Disclosure
16th Aug 20055:51 pmRNSEPT Disclosure
16th Aug 200510:12 amRNSEPT Disclosure
15th Aug 200510:54 amRNSEPT Disclosure
9th Aug 200510:59 amRNSEPT Disclosure
5th Aug 200510:56 amRNSEPT Disclosure
4th Aug 200510:13 amRNSEPT Disclosure
3rd Aug 200511:51 amRNSRule 8.3- Camellia plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.